TRAIL (Apo-2L) and TRAIL receptors in human placentas: Implications for immune privilege

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 6053-6059

  Phillips, Teresa A ^a   Ni, Jian ^c   Pan, Guohua ^d   Ruben, Steven M ^c   Wei, Ying Fei ^c   Pace, Judith L ^b   Hunt, Joan S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c GLAXOSMITHKLINE   (United States)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIGAND; MESSENGER RNA; RECEPTOR; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MESENCHYME; PLACENTA; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

APOPTOSIS REGULATORY PROTEINS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; MACROPHAGES; MEMBRANE GLYCOPROTEINS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033563139     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Streilein, J. W. 1995. Unraveling immune privilege. Science 270:1158.
2. Hunt, J. S., and H. Hutter. 1996. Current theories on protection of the fetal semiallograft. In HLA and the Maternal-Fetal Relationship. J. S. Hunt, ed. Landes Pub. Co., Austin, p. 27.
3. Vince, G. S., and P. M. Johnson. 1996. Reproductive immunology: conception, contraception and its consequences. Immunologist 4/5:172.
4. Hunt, J. S., and P. M. Johnson. 1997. Immunology of reproduction. In Encyclopedia of Reproduction, Vol. 2. E. Knobil and J. D. Neill, eds. Academic Press, New York, in press.
5. Fox, H. 1978. Pathology of the Placenta. W. B. Saunders, Philadelphia, p. 1.
6. Benirschke, K., and P. Kaufmann. 1995. Pathology of the Human Placenta, 3rd Ed. Springer-Verlag, New York, p. 1.
7. Chen, H.-L., Y. Yang, X.-L. Hu, K. K. Yelavarthi, J. L. Fishback, and J. S. Hunt. 1991. Tumor necrosis factor-α mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am. J. Pathol. 139:327.
8. Runic, R., C. J. Lockwood, Y. Ma, B. Dipasquale, and S. Guller. 1996. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J. Clin. Endocrinol. 81:3119.
9. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C.-P. Huang, J. K. Nicholl, G. R. Sutherland, T. Davis Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
10. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687.
11. Golstein, P. 1997. Cell death: TRAIL and its receptors. Curr. Biol. 7:R750.
12. Kabelitz, D. 1998. Apoptosis, graft rejection, and transplantation tolerance. Transplantation 65:869.
13. Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg, and M. E. Peter. 1998. Apoptosis signaling by death receptors. Eur. J. Biol. 254:439.
14. Snell, V., K. Clodi, S. Ahao, R. Goodwin, E. K. Thomas, S. W. Morris, M. E. Kadin, F. Cabanillas, M. Andreeff, and A. Younes. 1997. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br. J. Haematol. 99:618.
15. Katsikis, P. D., M. E. Garcia-Ojeda, J. F. Torres-Roca, I. M. Tijoe, C. A. Smith, and L. A. Herzenberg. 1997. Interleukin-1β converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. J. Exp. Med. 186:1365.
16. Yeh, W.-C., J. L. de la Pompa, M. E. McCurrach, H.-B. Shu, A. J. Elia, A. Shahinian, M. Ng, A. Wakeman, W. Khoo, K. Mitchell, et al. 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279:1954.
17. Mariani, S. M., and P. H. Krammer. 1998. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur. J. Immunol. 28:973.
18. Jeremias, L. I. Herr, T. Boehler, and K. M. Debatin. 1998. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28:143.
19. Pan, G., K. O. Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111.
20. Pan, G., J. Ni, Y.-F. Wei, G.-I. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815.
21. Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N. Boiani, M. S. Timour, M. J. Gerhart. K. A. Schooley, C. A. Smith, et al. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16:5386.
22. Screaton, G. R., J. Mongkolsapaya, X.-N. Xu, A. E. Cowper, A. J. McMichael, and J. I. Bell. 1997. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr. Biol. 7:693.
23. MacFarlane, M., M. Ahmad, S. M. Srinivasula, T. Fernandes-Alnemri, G. M. Cohen, and E. S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272:25417.
24. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, et al. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
25. Wu, G. S., T. F. Burns, E. R. McDonald III, W. Jiang, R. Meng, I. D. Krantz, G. Kao, D.-D. Gar, J.-Y. Zhou, R. Muschel, et al. 1997. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17:141.
26. Degli-Esposti, M. A., P. J. Smolak, H. Walczak, J. Waugh, C.-P. Huang, R. F. DuBose, R. G. Goodwin, and C. A. Smith. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186:1165.
27. Schneider, P., M. Thome, K. Burns, J.-L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, and J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7:831.
28. Chaudhary, P. M., M. Eby, A. Jasmin, A. Bookwalter, J. Murray, and L. Hood. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway Immunity 7:821.
29. Mongkolsapaya, J., A. E. Cowper, X.-N. Xu, A. J. McMichael, J. I. Bell, and G. R. Screaton. 1998. Cutting edge: lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. J. Immunol. 159:3.
30. Marsters, S. A., J. P. Sheridan, R. M. Pitti, A. Huang, M. Skubatch, D. Baldwin, J. Yuan, A. Gurney, A. D. Goddard, P. Godowski, and A. Ashkenazi. 1997. A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7:1003.
31. Degli-Esposti, M. A., W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith, and R. G. Goodwin. 1991. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7:813.
32. Pan, G., J. Ni, G. Yu, Y.-F. Wei, and V. M. Dixit. 1998. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett. 424:41.
33. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
34. Guilbert, L., S. A. Robertson, and T. G. Wegmann. 1993. The trophoblast as an integral component of a macrophage-cytokine network. Immunol. Cell Biol. 71: 49.
35. Van Parijs, L., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243.
36. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
37. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
38. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
39. Haynes, M. K., K. S. Shepley, L. G. Jackson, R. S. Tuan, and J. B. Smith. 1993. Cytokine production in first trimester chorionic villi: detection of mRNAs and protein products in situ. Cell. Immunol. 151:300.
40. Bulmer, J. N., L. Morrison, P. M. Johnson, and A. Meager. 1990. Immunohistochemical localization of interferons in human placental tissues in normal, ectopic and molar pregnancy. Am. J. Reprod. Immunol. 22:109.
41. Peyman, J. A., and G. L. Hammond. 1992. Localization of IFN-γ receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expression by IFN-γ. J. Immunol. 149:2675.
42. Vince, G. S., and P. M. Johnson. 1996. Immunobiology of human uteroplacental macrophages: friend and foe? Placenta 17:191.
43. Griffith, T. S., W. A. Chin, G. C. Jackson, D. H. Lynch, and M. Z. Kubin. 1998. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol. 161:2833.
44. Rieger, J., U. Naumann, T. Glaser, A. Ashkenazi, and M. Weller. 1998. Apo2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett. 427:124.